Personalized Anesthesia: The Role of the Locus Coeruleus in Individual Anesthetic Responses

个性化麻醉:蓝斑在个体麻醉反应中的作用

基本信息

  • 批准号:
    10799159
  • 负责人:
  • 金额:
    $ 13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Millions of patients are placed into a reversible state of unconsciousness by anesthesiologists for life saving surgeries every year. The basic goals of anesthetic care are to reliably extinguish consciousness for the duration of surgery and afterwards swiftly return the patient to their baseline cognitive state. Neither one of these goals can be reliably achieved today, however. Some patients regain consciousness during surgery. Episodes of consciousness are not reliably detected by current intraoperative EEG-based monitoring and can result in post-traumatic stress and anxiety disorders. In contrast, other patients take a long time to resume normal cognition. This can manifest as postoperative delirium and cognitive derangements. Postoperative delirium affects millions of patients, costs 34 billion dollars annually, and can itself be a harbinger of cognitive dcline after surgery. Such persistent decrements in cognitive function can last for many months. It is presently unclear why some patients experience peri-anesthetic complications while other patients that receive seemingly identical anesthetics have an uneventful perioperative course. To address this, we propose to study individual-based anesthetic pharmacology rather than previously used population-based measures. We have recently developed experimental and computational methods to quantify individual-based measures of anesthetic responses in mice. The use of these methods revealed that conventional population-based pharmacological concepts such as drug potency are not sufficient to describe individual responses. We identified two independent measures that do capture the range of individual responses: sensitivity and resistance to state transitions (Rst). Sensitivity describes how often an individual is awake or anesthetized at an anesthetic dose, while Rst describes how frequently transitions happen between those two states. We demonstrated that sensitivity and Rst can be differentially pharmacologically modulated. We also demonstrated that chemogenetic activation of an arousal pathway – locus coeruleus – decreases Rst without a change in drug sensitivity. Because Rst is completely obscured in population-based pharmacological studies, we hypothesize that Rst is the “hidden variable” that may help explain why some patients experience peri-anesthetic complications while others do not. We propose to investigate the mechanisms through which the locus coeruleus decreases Rst. Using pharmacologic and genetic approaches, we will identify the neurotransmitter systems used by the locus coeruleus to modulate Rst. Separately, we will identify the effects of the locus coeruleus on neurophysiologic state change, including correlates of behavioral Rst, using a high-density EEG system developed by our lab. Finally, we will turn towards identifying the neuronal pathways through which locus coeruleus acts to modulate Rst. The proposed lines of investigation will clarify how activity of the locus coeruleus influences individualized anesthetic responses, and will be an important step towards delivering personalized anesthesia.
项目总结/文摘

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
One node among many: sevoflurane-induced hypnosis and the challenge of an integrative network-level view of anaesthetic action.
许多节点中的一个:七氟烷诱导的催眠和麻醉作用的综合网络级视图的挑战。
  • DOI:
    10.1016/j.bja.2023.11.002
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    McKinstry-Wu,AndrewR;Kelz,MaxB
  • 通讯作者:
    Kelz,MaxB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Rich McKinstry-Wu其他文献

Andrew Rich McKinstry-Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew Rich McKinstry-Wu', 18)}}的其他基金

Personalized Anesthesia: The Role of the Locus Coeruleus in Individual Anesthetic Responses
个性化麻醉:蓝斑在个体麻醉反应中的作用
  • 批准号:
    10274962
  • 财政年份:
    2021
  • 资助金额:
    $ 13万
  • 项目类别:
Personalized Anesthesia: The Role of the Locus Coeruleus in Individual Anesthetic Responses
个性化麻醉:蓝斑在个体麻醉反应中的作用
  • 批准号:
    10665091
  • 财政年份:
    2021
  • 资助金额:
    $ 13万
  • 项目类别:
Intersections of Sleep and Coma: Neural Pathways of Alpha-2 Adrenergic Hypnosis
睡眠与昏迷的交叉点:Alpha-2 肾上腺素催眠的神经通路
  • 批准号:
    9906236
  • 财政年份:
    2017
  • 资助金额:
    $ 13万
  • 项目类别:
Intersections of Sleep and Coma: Neural Pathways of Alpha-2 Adrenergic Hypnosis
睡眠与昏迷的交叉点:Alpha-2 肾上腺素催眠的神经通路
  • 批准号:
    9293823
  • 财政年份:
    2017
  • 资助金额:
    $ 13万
  • 项目类别:
Intersections of Sleep and Coma: Neural Pathways of Alpha-2 Adrenergic Hypnosis
睡眠与昏迷的交叉点:Alpha-2 肾上腺素催眠的神经通路
  • 批准号:
    10361385
  • 财政年份:
    2017
  • 资助金额:
    $ 13万
  • 项目类别:

相似海外基金

Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8358448
  • 财政年份:
    2012
  • 资助金额:
    $ 13万
  • 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8517552
  • 财政年份:
    2012
  • 资助金额:
    $ 13万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7952159
  • 财政年份:
    2009
  • 资助金额:
    $ 13万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7952152
  • 财政年份:
    2009
  • 资助金额:
    $ 13万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7719194
  • 财政年份:
    2008
  • 资助金额:
    $ 13万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7605416
  • 财政年份:
    2007
  • 资助金额:
    $ 13万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7605425
  • 财政年份:
    2007
  • 资助金额:
    $ 13万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7378753
  • 财政年份:
    2006
  • 资助金额:
    $ 13万
  • 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
  • 批准号:
    6825160
  • 财政年份:
    2004
  • 资助金额:
    $ 13万
  • 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
  • 批准号:
    2702283
  • 财政年份:
    1997
  • 资助金额:
    $ 13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了